Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors

gan Chan, Jennifer A., Mayer, Robert J., Jackson, Nadine, Malinowski, Paige, Regan, Eileen, Kulke, Matthew H.
Cyhoeddwyd 2013

Feasibility and Acceptability of a Mobile Phone App Intervention for Coping With Cancer as a Young Adult: Pilot Trial and Thematic Analysis

gan Poort, Hanneke, Ryan, Annelise, MacDougall, Katelyn, Malinowski, Paige, MacDonald, Anna, Markin, Zach, Pirl, William, Greer, Joseph, Fasciano, Karen
Cyhoeddwyd yn J Med Internet Res (2021)

Phase I Study of Pasireotide (SOM 230) and Everolimus (RAD001) in Advanced Neuroendocrine Tumors

gan Chan, Jennifer A., Ryan, David P., Zhu, Andrew X., Abrams, Thomas A, Wolpin, Brian M, Malinowski, Paige, Regan, Eileen M, Fuchs, Charles S., Kulke, Matthew H.
Cyhoeddwyd yn Endocr Relat Cancer (2012)

Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study

gan Phan, Alexandria T, Halperin, Daniel M, Chan, Jennifer A, Fogelman, David R, Hess, Kenneth R, Malinowski, Paige, Regan, Eileen, Ng, Chaan S, Yao, James C, Kulke, Matthew H
Cyhoeddwyd yn Lancet Oncol (2015)